SCHEMBL10530596

SCHEMBL10530596

CC(C)CC(C)(N)CN.[Pt]

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792114 0.97
SCHEMBL10534330 0.87
SCHEMBL4734106 0.87
SCHEMBL10627312 0.87
SCHEMBL964999 0.82 AAK1 (0.32)
SCHEMBL22490938 0.78
SCHEMBL22931708 0.78 ALDH1A1 (0.33) CYP2D6
SCHEMBL17975609 0.74
SCHEMBL1830374 0.74
SCHEMBL21236172 0.74 CYP2D6 (0.30) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0155705-B1 ANTITUMOR PLATINUM COMPLEXES Bristol-Myers Squibb Company (US) 1989-12-13 EP disclosed
EP-0318464-A2 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1989-05-31 EP disclosed
EP-0306605-A1 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1989-03-15 EP disclosed
US-4594418-A A 1,2-cyclohexane platinum complex BRISTOL-MYERS COMPANY (US) 1986-06-10 US disclosed
US-4562275-A ANTICARCINOGENIC AGENTS BRISTOL-MYERS CO. (US) 1985-12-31 US disclosed
EP-0155705-A2 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1985-09-25 EP disclosed